• Profile
Close

An intronic HCP5 variant is associated with age of onset and susceptibility to Graves’ disease in UK and Polish cohorts

Journal of Clinical Endocrinology and Metabolism Jun 10, 2020

Lane LC, Kuś A, Bednarczuk T, et al. - In the present study, the researchers sought to explore the correlation of the HLA complex P5 (HCP5) variant rs3094228 with Graves’ disease (GD) susceptibility and age of onset in a UK cohort and perform a meta-analysis of UK and Polish data. Using Taqman chemistry, rs3094228 was genotyped in 469 UK patients with GD. Using logistic regression analysis, genotype frequencies were contrasted to genotypic data available from the Wellcome Trust case-control consortium. According to findings, the rs3094228 HCP5 polymorphism is independently linked to GD susceptibility and age of onset in a UK GD cohort. The outcomes show a potential role for long non-coding RNAs, including HCP5, in GD pathogenesis, particularly among the younger population.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay